1 Alterations of 5-hydroxytryptaminergic mechanisms are thought to play a special role in the pathogenesis of depression and antidepressant treatments are assumed to restore these changes. 2 We have used one of the most reliable models of depression, the olfactory bulbectomized rat to study the long term consequences of this manipulation and of subchronic imipramine treatment on two parameters of 5-hydroxytryptaminergic presynapses, 5-hydroxytryptamine (5-HT) transporter density and tryptophan hydroxylase apoenzyme concentration, in the frontal cortex as well as on active avoidance learning several weeks after bulbectomy. 3 The B max value of [ 3 H]-paroxetine binding and the concentration of the 5-HT synthesizing enzyme were both signi®cantly elevated in the frontal cortex of bulbectomized rats compared to sham-operated controls. 4 Imipramine treatment, either by daily injections or by subcutaneous implantation of slow release imipramine-containing polymers reduced the elevated tryptophan hydroxylase apoenzyme levels in the frontal cortex of bulbectomized, but not of sham-operated control rats and restored the de®cient learning performance of bulbectomized rats. 5 Both eects were more pronounced after continuous drug administration by imipramine-releasing polymers compared to daily i.p. injections. 6 These ®ndings indicate that bulbectomy leads to a compensatory 5-hydroxytryptaminergic hyperinnervation of the frontal cortex. Chronic antidepressant treatment seems to attenuate the increased output of the 5-hydroxytryptaminergic projections in the frontal cortex through the destabilization of the rate limiting enzyme of 5-HT synthesis of the 5-hydroxytryptaminergic nerve endings in this brain region.
Introduction
Alterations of the central 5-hydroxytryptaminergic (5-HT) system are generally believed to play a special role in the pathogenesis of depression and chronic antidepressant treatments are assumed to somehow restore these changes. This view is supported by altered CSF-levels of 5-hydroxyindole acetic acid (5-HIAA) in depressive patients (van Praag, 1984; Meltzer & Lowry, 1987) , by 5-HT transporter and receptor changes in postmortem brain samples (Yates et al., 1990; Leake et al., 1991) , by the relapse of depressive symptomatology in remitted patients after acute tryptophan-depletion (Delgado et al., 1990) , by the rather consistent down-regulation of 5-HT 2 -receptors associated with antidepressant treatments and by the antidepressant action of selective 5-HT drugs such as 5-HT 1A agonists or selective 5-HT reuptake inhibitors (for reviews see Briley, 1993; Blier & de Montigny, 1994) . Several aspects of these neurochemical impairments and drug actions have been con®rmed in numerous experimental studies with dierent animal models of depression (Jesberger & Richardson, 1985; Willner, 1989; Richardson, 1991) , but a consistent picture of the role of the 5-HT system and its derangement in the brain of depressive patients is still elusive. This is at least partially due to the fact that many of the models employed fail to simulate the human disease conditions closely enough. Ideally, an animal model should induce signi®cant and stable alterations in normal brain functions which are associated with measurable behavioural and neurochemical changes and which are normalized only by chronic, but not by acute, administration of clinically ecacious antidepressants (Jesberger & Richardson, 1985) . The olfactory bulbectomized rat is one of the few models to which these criteria apply. Bilateral destruction of the olfactory bulbs in the rat induces a number of behavioural changes, including increased locomotor activity and de®cits in active and passive avoidance tasks (Cairncross et al., 1979; Leonard & Tuite, 1981; van Riezen & Leonard, 1990) . These behavioural impairments are rather selectively normalized by chronic not by acute administration of many dierent typical and atypical antidepressants (Leonard et al., 1989; Richardson, 1991) . The time course of this behavioural normalization was found to coincide with restoration of biochemical parameters, such as decreased 5-HT 2 receptor density in frontal cortex of bulbectomized rats (Gurevic et al., 1993; Song & Leonard, 1994; Mudunkotuwa & Horton, 1996) . This impressive selectivity of the olfactory bulbectomy model for drugs with antidepressant actions in patients and the remarkable speci®city of the action of these drugs on behavioural and biochemical parameters suggest that the analysis of the neurochemical impairments seen in olfactory bulbectomized rats, of their responses to antidepressant treatment and their relationship to the treatment related behavioural changes, may be a useful strategy to uncover the neurobiological substrates of human major depressive disorder. It is one of the most interesting features of this model that removal of the olfactory bulbs will produce not only a disruption of local neuronal circuitry but also initiate a sequence of secondary compensatory structural and functional alterations in brain areas which are far remote from the lesion (Jesberger & Richardson, 1988) . These lesion-induced reorganization processes in limbic and cortical areas, rather than the anosmia per se, appear to be responsible for the secondary, late appearing behavioural abnormalities seen in bulbectomized rats (Tiany et al., 1979; Jesberger & Richardson, 1988; van Riezen & Leonard, 1990) . Antidepressant treatments must therefore be assumed to restore these aberrant behaviours through the long-term attenuation of the impact of this newly formed connectivity on global information processing in the brain.
Several observations suggest that an impairment of the central 5-HT system may play a special role in the behavioural changes caused by bulbectomy and that the restoration of certain impairments of the central 5-HT system is closely related to the behavioural normalization seen after chronic antidepressant treatments. Firstly, many of the biochemical and behavioural eects seen after surgical ablation of the bulbs are likewise produced by the selective destruction of its 5-hydroxytryptaminergic innervation by intrabulb injections of 5, 6-dihydroxytryptamine (Cairncross et al., 1977) . Secondly, several behavioural changes seen in bulbectomized rats have been attributed to an imbalance between the central 5-hydroxytryptaminergic and noradrenergic systems (for review see Cairncross et al., 1979) . Thirdly, chronic administration of selective 5-HT reuptake inhibitors has been shown to attenuate or reverse the impairments in behaviour, neurotransmitters and immune functions in bulbectomized rats (Song & Leonard, 1994) . Finally, the time course of normalization of altered behavioural responsiveness in bulbectomized rats caused by chronic desipramine administration coincides with the down-regulation of 5-HT 2A receptors, but not of b-adrenoceptors in the frontal cortex (Mudunkotuwa & Horton, 1996) .
Until now, research on this and other animal models of depression has almost exclusively been focused on changes of postsynaptic 5-HT receptors. Very little is presently known about possible alterations of presynaptic parameters of 5-HT neurotransmission. This is a serious¯aw since usually such changes will precede and act as triggers for the up-or downregulation of postsynaptic 5-HT receptors. The current lack of knowledge about the alterations of 5-HT presynaptic mechanisms imposes a serious limitation to the interpretation of postsynaptic changes of receptor densities or intracellular signal transduction mechanisms. The need of such an investigation is underlined by an increasing number of studies demonstrating an amazing degree of structural plasticity of the 5-HT innervation pattern in the adult brain (for reviews see Azmitia & Whitaker-Azmitia, 1991; Jacobs & Azmitia, 1992) . In the ascending 5-HT projections originating in the pontine and midbrain raphe nuclei, extensive collaborative sprouting and regeneration phenomena have been observed after lesions all along the course of the medial forebrain bundle (Bjorklund et al., 1981; Ueda & Kawata, 1994) . The reinnervation of projection ®elds after the selective destruction of 5-HT eerences is a rather slow process and may even lead to a 5-HT hyperinnervation of certain regions (Bjorklund et al., 1973; Zhou et al., 1995) . Early histo¯uorescent studies of indoleamine accumulation in dierent brain regions revealed an increased indoleamine¯uorescence in the olfactory tubercle and the piriform cortex 5 weeks after olfactory bulbectomy in mice (Garris et al., 1984) . This ®nding, together with our recent observation of a simultaneous increase of the density of 5-HT transporters and of tryptophan hydroxylase apoenzyme concentrations in the frontal cortex of bulbectomized rats , suggests that one of the slow, secondary events associated with the reorganization of neuronal circuits is a compensatory 5-HT hyperinnervation of anterior cortical regions.
The present study was performed in order to assess the inuence of long-term antidepressant treatment on two speci®c parameters of 5-HT presynapses, [ These biochemical studies were combined with a behavioural analysis of the eects of a subchronic antidepressant treatment on the learning de®cit of these bulbectomized rats in a one-way active avoidance task, the pole jumping test. Imipramine, one of the most thoroughly studied and most widely medicated antidepressants was chosen for this study and chronically applied either by daily injections or by subcutaneous implants of slow-release imipramine-containing polymers.
Methods

Animals
For all experiments male Wistar rats were used (Mol:Wist/ Shoe-strain, Moellegard Breeding Center, Germany). The animals were housed in groups of ®ve rats per cage under controlled laboratory conditions (temperature 20 + 28C, relative air humidity 55 ± 60%, LD 12 : 12, light on at 06 h 00 min) with free access to complete standard diet (Altromin 1326) and tap water.
All animal experiments were conducted in accordance to the requirements of the National Act on the Use of Experimental Animals in Germany and approved by the`Tierschutzkommission des Landes Sachsen-Anhalt'.
Bulbectomy
Bilateral olfactory bulbectomy was performed as described by O'Connor & Leonard (1986) . Brie¯y, rats were anaesthetized with pentobarbitone (40 mg kg 71 , i.p.). The animals were ®xed in a stereotactic instrument and a skin incision was made to expose the skull overlying the bulbs. Two 2 mm diameter holes were drilled above the bulbs (6.5 mm anterior to bregma and 2 mm on both sides) and both holes were joined to a slotted hole. The olfactory bulbs were cut and removed by aspiration by use of a de¯ected pipette. The resulting spaces were ®lled with haemostatic sponges and the skin closed by tissue adhesive. Sham-operated rats were treated in the same way, including piercing of the dura mater but their bulbs were left intact.
The rats were bulbectomized at the age of 7 weeks (body weight 220 ± 280 g). After seven weeks, when the behavioural experiments were performed, the body weights were 350 ± 450 g. There were no dierences in body weights between bulbectomized and control animals. At the end of the experiments, when the brains were removed for neurochemical analysis, each brain was checked to ensure that the olfactory bulbs had been completely removed and that there was no damage to the frontal cortex.
Imipramine treatment
Acute administration In order to assess the in¯uence of acute imipramine administration on performance in the active avoidance task, imipramine was injected one hour before each training session (20 mg kg 71 , i.p., in saline, 10 ml kg 71 body weight). Control animals received saline injections Subchronic administration The subchronic treatment with imipramine or saline was started 6 ± 7 weeks after bulbectomy and exactly 11 days before the learning experiments. Imipramine was administered either by daily i.p. injections (3.75 mg kg 71 body weight in saline) or by subcutaneous slowrelease implants. For this purpose, ethylene vinyl acetate copolymers containing 50% (wt/wt) imipramine (length: 40 mm, diameter: 5 mm) were prepared as described elsewhere (Sabel et al., 1990) . These polymers released about 3.75 mg imipramine kg 71 body weight per day, as measured spectrophotometrically before their implantation and after their removal at the end of the treatment period of 17 days. Imipramine-containing or empty polymers were implanted under the neck skin and removed at the end of the experiment (one day after the last training session) under anaesthesia.
The following treatment groups were formed: (1) shamoperated animals with blank-polymers and daily i.p. injections of saline (Bulb-C/Sal). (2) All treatments were continued until the last training session. Intraperitoneal imipramine injections were given one hour before the training sessions. Injections were ®nished before, and polymers were removed the day after the last training session.
Learning test: pole-jumping
Seven to eight weeks after surgery and 11 days after the start of the subchronic imipramine treatment, the learning performance of the animals was tested in a one-way active avoidance task, the pole jumping test. In this test, the rat had to learn to jump on a pole to avoid electric foot-shocks. The conditioned stimulus was a sound produced by a buzzer. The unconditioned stimulus was an electric foot-shock (pulsatile direct current with a frequency of 50 Hz, 10 ms pulse-width, intensity according to the individual susceptibility, maximum 0.8 mA) delivered through stainless steel rods covering the¯oor. The conditioning-unconditioned stimulus interval was 4 s. One trial was limited to 20 s when an animal failed to jump on the pole within this period. Each session consisted of 10 trials and was repeated over a period of ®ve consecutive days. All sessions were performed during the light period of the 12 h light 12 h dark cycle at about the same time. Before the ®rst session, the rats were allowed to explore the box for 5 min, on the following days 1 min was provided for exploration. The number of escapes (instrumental reactions 4 4 s, reaction time 5 20 s) and conditioned reactions (reaction time 5 4 s) were recorded for further evaluation.
Sample preparation and measurements of neurochemical parameters
One week after the discontinuation of the daily imipramine injections or removal of the implanted polymers, the rats were killed by decapitation. The brains were quickly removed, frozen in liquid nitrogen and stored at 7808C until further analysed.
The frontal cortices were dissected and processed as described recently . Brie¯y, tissues were homogenized and centrifuged to obtain cytoplasmatic supernatant samples for measurements of tryptophan hydroxylase apoenzyme concentrations. The pellets were repeatedly resuspended and centrifuged to prepare partially puri®ed membrane samples for measurements of 5-HT transporter densities.
The concentration of the tryptophan hydroxylase apoenzyme in the frontal cortex of the dierently treated rats were measured by a double sandwich ELISA, by use of a monoclonal antibody against tryptophan hydroxylase for speci®c binding and a polyclonal antiserum for detection. For the assesssment of treatment-related changes in 5-HT transporter densities, the B max value of [ 3 H]-paroxetine binding was determined by a highly speci®c ligand binding assay .
Protein concentrations in ELISA and binding samples were measured by the method of Lowry et al., (1951) .
Data analysis and statistics
To evaluate the learning performance of the animals, the repeated measures model was applied several times to test hierarchical hypotheses. The basis of statistical decision was a signi®cance level of P50.05. The calculations were carried out by SPSS/PC software (ANOVA and MANOVA). 
Results
Pole-jumping test
Sham-operated rats acquired the learning task rapidly (see Figures 1 and 2) . However, the learning performance of bulbectomized animals was extremely low. They did not perform the conditioned reactions (see Figures 1 and 2b) , and also the acquisition of the instrumental reaction was disturbed (see Figures 1 and 2a) . The acute administration of imipramine at a relatively high dose (20 mg kg 71 , i.p.) before each training session caused an almost complete normalization of the instrumental reactions in bulbectomized rats. However, their learning performance of the conditioned reactions was not signi®cantly improved and remained below the levels reached by sham-operated control rats (Figure 1b) . The learning performance of control animals was signi®cantly impaired by the acute imipramine injections.
Subchronic imipramine treatment of the bulbectomized rats caused a signi®cant improvement of their learning performance which was more pronounced if the drug was continuously adminstered by the slow release imipramine containing polymers (Figure 2) . The daily i.p. injection of imipramine (3.75 mg kg 71 ) signi®cantly ameliorated the poor learning performance of conditioned reactions (Figure 2b ), but these animals still showed a lower learning performance if compared to control animals. If the same daily dose of imipramine was administered continuously by slow-release polymers, the bulbectomy induced learning de®cit was completely abolished. Both administration schedules completely restored the instrumental reaction (see Figure 2a) The double sandwich ELISA procedure used for measurements of tryptophan hydroxylase apoenzyme concentrations in supernatants of brain homogenates, employed a speci®c monoclonal antibody, was very sensitive (detection limit: 0.1 ng/well) and gave highly reproducible results (intraassay variance: 5 5%, interassay variance: 5 10%). In the frontal cortex of bulbectomized rats, a signi®cant increase in the concentrations of tryptophan hydroxylase apoenzyme was observed (Table 2 ). In sham-operated control rats, subchronic imipramine treatment, either by daily injections or by implants, had no eect on this parameter. In bulbectomized rats, a signi®cant reduction of the elevated tryptophan hydroxylase levels in the frontal cortex was noticed. This decline was somewhat more pronounced after the implantation of slowrelease imipramine containing polymers compared to the daily administration by i.p. injections (Table 2) .
Discussion
Compared to other animal models, the olfactory bulbectomized rat appears to be a particularly attractive model for studying the neurobiological basis of depression and the mechanisms of action of antidepressant drugs. Bulbectomy produces stable impairments of neurochemical and neuroendocrine mechanisms which are associated with measurable behavioural changes and which show striking similarities to disturbances observed in people with major depression Leonard, et al. 1989; Richardson, 1991) . Bulbectomized animals display a remarkable selectivity to drugs with antidepressant activity in man (Richardson, 1991) . Most of the bulbectomy-induced symptoms are alleviated by chronic but not by acute antidepressant treatment, and the time course of the actions of antidepressants in bulbectomized animals is reasonably similar to the time course of their clinical actions in depressive patients (Broekkamp et al., 1980; Joly & Sander, 1986) .
The results of our behavioural studies in bulbectomized and imipramine-treated rats con®rm the ®ndings of other groups, showing that bulbectomy leads to severe impairments in several learning tasks which are not reserved by acute but almost completely normalized following long-term treatment with dierent typical and atypical antidepressant drugs (for reviews see Leonard & Tuite, 1981; Leonard et al., 1989) . In the present study, the learning de®cit was validated by the pole-jumping test. Interestingly, the continuous administration of imipramine via slow release polymer implants was more eective in correcting this de®cit than the daily administration by i.p. injections. Likewise, also the continuous administration of antidepressants to severely depressed patients via permanent i.v. catheters was shown to cause greater improvements in depression scores at lower dosages, and therefore with fewer side eects, if compared to daily oral intake (Adler et al., 1997) .
Several attempts have been made by other groups to relate the behavioural alterations and their normalization by antidepressant treatments to alterations at the level of transmitter metabolism and receptor expression in the brain of bulbectomized rats. Apart from some isolated studies on alterations of g-aminobutyric acid (GABA)ergic (Jancsar & Leonard, 1984) and cholinergic (Broekkamp et al., 1986) mechanisms, the majority of changes was found in the noradrenergic and the 5-HT systems. Interestingly, the alterations were restricted to certain brain regions, such as the amygdala, hippocampus hypothalamus, or cerebral cortex. Many of these changes, e.g. the increased density of b-adrenoceptors in the hippocampus , the up-regulated 5-HT 2 -receptor density in the frontal cortex (Gurevich et al., 1993) or regional changes of 5-HT and noradrenaline contents as well as their metabolites (for review see Song & Leonard, 1995) were found to be reversed by chronic antidepressant treatments.
Only recently, the ®rst attempts were made to relate directly to the time course of such neurochemical changes to the behavioural changes seen in bulbectomized and antidepressant treated animals. The behavioural normalization of desipramine-treated bulbectomized rats was found to coincide with the down-regulation of 5-HT 2 -receptors in the frontal cortex but not with the down-regulation of b-adrenoceptors in this or any other brain region (Mudunkotuwa & Horton, 1996) . This ®nding, in conjunction with our previous demonstrations of an elevated 5-HT transporter density, tryptophan hydroxylase apoenzyme concentration and higher 5-HIAA/5-HT-ratio in the frontal cortex (and no other brain regions) of bulbectomized rats , suggests that a local and speci®c alteration of 5-HT neurotransmission in the frontal cortex may be related to the long-lasting changes in behavioural responsiveness caused by bulbectomy. The striking parallelism seen in the present study between the eectiveness of the two dierent schedules of imipramine treatment employed, on the normalization of active avoidance learning and the decline of tryptophan hydroxylase levels in the frontal cortex, supports the view that the behavioural normalization of antidepressant treated bulbectomized rats is related to a restoration of aberrant 5-HT mechanisms in the frontal cortex.
Most likely the concomitant elevation of all three speci®c markers of 5-HT presynapses indicates an increased 5-HT innervation density in the frontal cortex of bulbectomized rats. Due to the predominantly inhibitory, constraining eects of the 5-HT aerences on cortical information processing (Jacobs & Azmitia, 1992; Spoont, 1992) , such an increased 5-HT innervation density must be expected to suppress the general neuronal activity, and therefore the metabolic rate and blood ow in frontal cortical areas. In bulbectomized rats, no information about alterations of these parameters is presently available. However, it is an interesting corollary that a selective diminution of local blood¯ow and cerebral metabolic rate in anterior cortical areas are among the most consistent ®ndings of PET and SPECT studies in depressive patients (Bench et al., 1993; Drevets et al., 1994) . It has also been found that this frontal hypoperfusion is restored by antidepressant treatment (Mayberg et al., 1994) .
In our animal model, subchronic imipramine treatment reduced the bulbectomy-induced elevation of tryptophan hydroxylase in the frontal cortex, but had no eect on the level of this enzyme in the frontal cortex, of sham-operated controls. The selective action of subchronic imipramine treatment on the level of expression of the 5-HT synthesizing enzyme only in the 5-HT hyperinnervated, but not on the normally innervated, frontal cortex is the most interesting ®nding of this investigation. If a local imbalance in 5-HT output between functionally dierent brain regions causes an impaired balance in global neuronal activity patterns between such regions (and, consequently, characteristic alterations in behavioral reactivity), an eective treatment should act to restore this secondarily disturbed balance through the restoration of the original balance of the regional 5-HT output patterns. Such an eect may be achieved by dierent means. Drugs which act to down-regulate (tricyclic antidepressants) or to block 5-HT 2 -receptors (mianserin) will automatically have a greater in¯uence on 5-HTmediated eects in regions where these receptors are most abundantly expressed, i.e. the frontal cortex in rats (Leysen et al., 1982; Peroutka & Snyder, 1983) . The local down-regulation of tryptophan hydroxylase in the frontal cortex of bulbectomized rats by chronic imipramine treatment suggests the existence of an additional or alternative mechanism by which a disturbed balance in 5-HT output patterns may be restored, namely by a reduced synthesis, and therefore release, of 5-HT by 5-hydroxytryptaminergic presynapses. Since chronic antidepressant treatments do not aect the m-RNA content of this enzyme (Spurlock et al., 1994) , and since the down-regulation of this enzyme is only seen in the frontal cortex of bulbectomized rats, a global in¯uence of the imipramine treatment on the expression of this enzyme is not very likely. Rather, the subchronic imipramine treatment must be assumed to compromise the stability and to shorten the half-life of the enzyme selectively in 5-HT presynapses in the frontal cortex of bulbectomized rats. This strange eect may have a rather simple explanation, if we consider that this cytoplasmatic enzyme is particularly vulnerable to proteolytic damage and that it is normally protected by its substrate, tryptophan (Neckers et al., 1977; Kuhn et al., 1980; Vitto & Mandell, 1981) . The druginduced blockade of 5-HT reuptake depletes presynaptic 5-HT stores and causes a massive stimulation of 5-HT synthesis. The intrasynaptic availability of tryptophan declines and the stability of the enzyme becomes increasingly governed by the supply of tryptophan from external sources, i.e. the blood. Poorly perfused brain regions (the 5-HT hyperinnervated frontal cortex of bulbectomized rats or anterior cortical regions of depressive patients) are less eciently supplied by tryptophan and, therefore, the enzyme is less eciently protected against proteolytic degradation. As the levels of tryptophan hydroxylase fall, less 5-HT is released and consequently the regional imbalance in 5-HT output patterns is gradually restored and, therefore, the behavioural disturbance is normalized.
Further studies are needed in order to assess the validity of these assumptions. However, the heuristic value of this concept is quite remarkable. It may explain some unexpected clinical observations, e.g. that tryptophan availability has long been noticed to be a critical factor in the aetiology of depression and in the responsiveness to (certain) antidepressant treatments (Moller, 1987; Cowen et al., 1987) , and that successfully treated remitted patients are extremely vulnerable to a sudden decline of their tryptophan supply (Delgado et al., 1994) . Our demonstration that both bulbectomy and the subsequent antidepressant treatment aect presynaptic mechanisms, involved in the regulation of 5-HT output in the frontal cortex, raises serious concerns over the interpretation of many earlier ®ndings of alterations of postsynaptic 5-HT receptor densities in this and other animal models of depression (Gurevich et al., 1993; Berendsen, 1995; Mudunkotuwa & Horton, 1996) . It is possible that such postsynaptic 5-HT receptor changes are triggered by an altered presynaptic 5-HT output and therefore are of a secondary nature. Finally, even though the observed changes in 5-hydroxytryptaminergic mechanisms appear to be closely associated with the learning de®cit in bulbectomized rats and its reversal by subchronic antidepressant treatment, other transmitter systems may be aected as well. In particular, the possible changes in noradrenergic mechanisms are of interest in this respect and deserve a more thorough investigation in this animal model of depression.
